Jump to content

Thomas Kolb

From Wikipedia, the free encyclopedia

Thomas M. Kolb is an American radiologist specializing in the detection and diagnosis of breast cancer in young, predominantly high-risk premenopausal women. He has served as an assistant clinical professor of Radiology at Columbia University College of Physicians and Surgeons from 1994–2010. Kolb is double board certified, having received his training in pediatrics at the Albert Einstein College of Medicine in Bronx, New York, and in diagnostic radiology at the Columbia-Presbyterian Medical Center in New York.[1]

Kolb holds positions on the board of directors of the Breast and Prostate Cancer Research Foundation in New York, is chairman of the medical advisory committee of Sharsheret, and is part of the medical advisory committee for the Young Survival Coalition.[2] Kolb is a member of the New York Breast Cancer Study group, which co-authored the research publication "Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2" published in the journal Science in 2003 detailing the clinical effect of breast cancer genetic mutations.[3]

In 1998, Kolb published the first contemporary study detailing the use of breast ultrasound to detect cancers that are both mammographically and physically occult. His subsequent 2002 publication in the journal Radiology "Comparison of the Performance of Screening Mammography, Physical Examination and Breast US and Evaluation of the Factors that Influence Them: An Analysis of 27,825 Patient Evaluations" was chosen as the scientific paper of the year by the American Medical Association (AMA) science writers group for the year 2002. The study identified breast density as an important factor in the effectiveness of mammography, and reported that the additional use of ultrasound could significantly improve early breast cancer detection rates for women with dense breasts.[4][5][6][7][8]

Kolb has been a manuscript reviewer for the journal Radiology.[9] His manuscripts and research have focused on the critical evaluation of current breast cancer screening modalities, genetic predispositions to breast cancer, and the use of novel techniques and technologies, such as infrared and electrical impedance imaging, for the detection and diagnosis of breast cancer.[citation needed]

Kolb is a principal investigator of the North American Digital Breast Tomosynthesis project trial, which is analyzing a novel mammographic technology that acquires multiplanar images of the breasts.

Kolb is a member of numerous professional organizations including the American Roentgen Ray Society, the Radiological Society of North America, the Society of Breast Imaging and the New York Metropolitan Breast Cancer Group. He is a fellow of the American College of Radiology and a fellow of the American Academy of Pediatrics.

Selected publications

[edit]
  • Kolb, T. M.; Lichy, J.; Newhouse, J. H. (April 1998). "Occult cancer in women with dense breasts: detection with screening US--diagnostic yield and tumor characteristics". Radiology. 207 (1): 191–199. doi:10.1148/radiology.207.1.9530316. ISSN 0033-8419. PMID 9530316.
  • Kolb, Thomas M.; Lichy, Jacob; Newhouse, Jeffrey H. (October 2002). "Comparison of the Performance of Screening Mammography, Physical Examination, and Breast US and Evaluation of Factors that Influence Them: An Analysis of 27,825 Patient Evaluations". Radiology. 225 (1): 165–175. doi:10.1148/radiol.2251011667. ISSN 0033-8419. PMID 12355001.
  • King, Mary-Claire; Marks, Joan H.; Mandell, Jessica B.; New York Breast Cancer Study Group (24 October 2003). "Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2" (PDF). Science. 302 (5645): 643–646. Bibcode:2003Sci...302..643K. doi:10.1126/science.1088759. PMID 14576434.

References

[edit]
  1. ^ "Reporting the Research: What's Real News in Breast Cancer and Ovarian Cancer? National Teleconference & Webinar Transcript Wednesday, October 26, 2011" (PDF). Sharsheret. Retrieved 13 May 2024.
  2. ^ "Medical Advisory Board, Young Survival Coalition". youngsurvival.org. Retrieved February 6, 2014.
  3. ^ King, Mary-Claire; Marks, Joan H.; Mandell, Jessica B.; New York Breast Cancer Study Group (24 October 2003). "Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2" (PDF). Science. 302 (5645): 643–646. Bibcode:2003Sci...302..643K. doi:10.1126/science.1088759. PMID 14576434.
  4. ^ Gottlieb, Scott (Sep 28, 2002). "Ultrasound plus mammography may detect more early cancers". BMJ. 325 (7366): 678. PMC 1169487.
  5. ^ "Ultrasound finds breast cancer that mammogram might miss". Tampa Bay Times. September 20, 2002.
  6. ^ Schmid, Randolph E. (September 20, 2002). "Physician: Ultrasound can help spot breast cancer". Wilmington Star-News. Retrieved 13 May 2024.
  7. ^ Galvin, J. Robert; Gyle, Norma D. (2006). "REPORT TO THE GENERAL ASSEMBLY AN ACT CREATING A PROGRAM FOR QUALITY IN HEALTH CARE JUNE 2006" (PDF). State of Connecticut. Department of Public Health.
  8. ^ Schattner, Elaine (Feb 16, 2015). "All Women Should Have Access To Ultrasound Screening For Breast Cancer". Forbes.
  9. ^ Jost, R. Gilbert; Proto, Anthony V. (December 2007). "Manuscript Reviewers: A Note of Thanks". Radiology. 245 (3): 622–627. doi:10.1148/radiol.2453071623. ISSN 0033-8419.